Bausch Health Companies Inc T.BHC

Alternate Symbol(s): BHC

Healthcare

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

TSX:BHC - Post by User

Bausch Health Companies Inc > Delaware

<< Previous

Bullboard Posts

Next >>

Comment by savyinvestor333on Jul 28, 2022 4:08pm

161 Views

Post# 34858082

RE:RE:RE:RE:Delaware

savyinvestor333 wrote:

RusticHit wrote: I think this will go down to 2-3 bucks lots of Debt and revenue stream cutting Off not good Debt is way too much

And that is what makes a markrt. I see a 20% jump on reopening.

Humm after market trading in U.S. shows the stock up 23% and rising from the halt Now trading at $5.26 U.S.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023